Chemokines and chemokine receptors in the pathogenesis of systemic sclerosis

References

• Jimenez SA, Hitraya E, Varga J. Pathogenesis of sderoderma. Collagen. Rheum Dis Clin North Am 1996;22:647–74.
   PubMed Web of Science ®Google Scholar
• White B. Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 1996;22:695–708.
   PubMedGoogle Scholar
• Kfihdri VM, Sandberg M, Kalimo H, Vuorio T, Vuorio E. Identification of fibroblasts responsible for increased collagen pro-duction in localized scleroderma by in situ hybridization. J Invest Dermatol 1988;90:664–70.
   Google Scholar
• White B. Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 1996;22:695–708.
   PubMedGoogle Scholar
• Gay S, Jones REJ, Huang GO, Gay RE. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 1989;92: 301–3.
   PubMed Web of Science ®Google Scholar
• Kowal-Bielecka 0, Distler 0, Neidhart M, Kunzler P, Rethage J, Nawrath M, et al. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified path-way to skin inflammation in systemic sclerosis. Arthritis Rheum 2001;44: 1865–75.
   Google Scholar
• Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123–8.
   PubMed Web of Science ®Google Scholar
• Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385(6617):640–4.
   PubMed Web of Science ®Google Scholar
• Thelen M. Dancing to the tune of chemokines. Nat Immunol 2001;2:129–34.
   PubMed Web of Science ®Google Scholar
• Zlotnik A, Yoshie 0. Chemokines: a new classification system and their role in immunity. Immunity 2000;12: 121–7.
   Google Scholar
• Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108–15.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Zhang N, Murphy DB, Devreotes PN. Dynamic distribu-tion of chemoattractant receptors in living cells during chemotaxis and persistent stimulation. J Cell Biol 1997;139:365–74.
   PubMedGoogle Scholar
• Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, Bourne HR. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 2000;287(5455):1037–40.
   PubMedGoogle Scholar
• Distler 0, Neidhart M, Gay RE, Gay S. The molecular control of angiogenesis. Int Rev Immunol 2002;21:33–49.
   PubMedGoogle Scholar
• Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, et al. CXC chemokines in angiogenesis. J Leukoc Biol 2000;68:1–8.
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, et al. FtANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent forma-tion and interstitial fibrosis. J Exp Med 1997;185:1371–80.
   PubMed Web of Science ®Google Scholar
• Zhang K, Gharaee-Kermani M, Jones ML, Warren JS, Phan SH. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J Immunol 1994;153:4733–41.
   PubMed Web of Science ®Google Scholar
• Kunkel SL. Through the looking glass: the diverse in vivo activities of chemokines. J Clin Invest 1999;104:1333–4.
   PubMedGoogle Scholar
• Holcombe FtF, Baethge BA, Stewart RM, Betzing K, Hall VC, Fukuda M, et al. Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels. Clin Immunol Immunopathol 1993;67:31–9.
   PubMedGoogle Scholar
• Reitamo S, Remitz A, Varga J, Ceska M, Effenberger F, Jimenez S, et al. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Arch Dermatol 1993;129:189–93.
   PubMedGoogle Scholar
• Koch AE, Kronfeld-Harrington LB, Szekanecz Z, Cho MM, Haines GK, Harlow LA, et al. In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology 1993;61:239–46.
   Google Scholar
• Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentrations in bronchoalveolar lavage fluid of pa-tients with systemic sclerosis. Arthritis Rheum 1997;40:743–51.
   Google Scholar
• Southcott AM, Jones KP, Li D, Majumdar S, Cambrey AD, Pantelidis P, et al. Interleukin-8. Differential expression in lung fibrosing alveolitis and systemic sclerosis. Am J Respir Crit Care Med 1995;151:1604–12.
   PubMed Web of Science ®Google Scholar
• Pantelidis P, Southcott AM, Black CM, Du Bois RM. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis. Clin Exp Immunol 1997;108: 95–104.
   Google Scholar
• Renzoni E, Lympany P, Sestini P, Pantelidis P, Wells A, Black C, et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis Rheum 2000;43:1633–40.
   PubMedGoogle Scholar
• Hasegawa M, Sato S, Takehara K. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macroph-age inflammatory protein-lalpha (MIP-lalpha) and MIP-lbeta) in patients with systemic sclerosis: MCP-1 and MIP-lalpha may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 1999;117: 159–65.
   Google Scholar
• Distler 0, Ftinkes B, Hohenleutner U, Scholmerich J, Landthaler M, Lang B, et al. Expression of FtANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis. Ftheumatol Int 1999;19:39–46.
   Google Scholar
• Distler 0, Pap T, Kowal-Bielecka 0, Meyringer R, Guiducci S, Landthaler M, et al. Overexpression of MCP-1 in systemic sclerosis: role of PDGF and effects on monocyte chemotaxis and collagen synthesis. Arthritis Rheum 2001; 44: 2665–78.
   Google Scholar
• Galindo M, Santiago B, Ftivero M, Rullas J, Alcami J, Pablos JL. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis Rheum 2001;44:1382–6.
   PubMedGoogle Scholar
• Yamamoto T, Eckes B, Hartmann K, Krieg T. Expression of monocyte chemoattractant protein-1 in the lesional skin of sys-temic sclerosis. J Dermatol Sci 2001;26:133–9.
   PubMed Web of Science ®Google Scholar
• Denton CP, Shi-Wen X, Sutton A, Abraham DJ, Black CM, Pearson JD. Scleroderma fibroblasts promote migration of mono-nuclear leucocytes across endothelial cell monolayers. Clin Exp Immunol 1998;114:293–300.
   PubMedGoogle Scholar
• Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun 2001;281: 200–5.
   Google Scholar
• Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997;151:1751–8.
   PubMed Web of Science ®Google Scholar
• Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, et al. Human endothelial cells express CCFt2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34–40.
   PubMed Web of Science ®Google Scholar
• Proudfoot AE, Power CA, Wells TN. The strategy of blocking the chemokine system to combat disease. Immunol Rev 2000;177:246–56.
   Google Scholar
• Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997;186: 131–7.
   Google Scholar
• Liang M, MaHari C, Rosser M, Ng HP, May K, Monahan S, et al. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem 2000;275(25):19000–8.
   PubMed Web of Science ®Google Scholar